MUSIANI, Piero
 Distribuzione geografica
Continente #
NA - Nord America 12.756
EU - Europa 8.127
AS - Asia 6.978
SA - Sud America 767
Continente sconosciuto - Info sul continente non disponibili 337
AF - Africa 112
OC - Oceania 15
Totale 29.092
Nazione #
US - Stati Uniti d'America 12.352
SG - Singapore 2.463
CN - Cina 2.193
RU - Federazione Russa 1.486
UA - Ucraina 1.458
GB - Regno Unito 1.084
TR - Turchia 1.057
IE - Irlanda 1.028
SE - Svezia 765
FR - Francia 689
BR - Brasile 632
IT - Italia 598
DE - Germania 510
VN - Vietnam 458
IN - India 316
FI - Finlandia 290
CA - Canada 186
BD - Bangladesh 126
MX - Messico 54
IL - Israele 53
HK - Hong Kong 52
AR - Argentina 45
PL - Polonia 43
IQ - Iraq 40
BE - Belgio 36
CZ - Repubblica Ceca 30
JP - Giappone 30
KR - Corea 30
CR - Costa Rica 29
ES - Italia 29
SC - Seychelles 28
ZA - Sudafrica 26
PK - Pakistan 25
VE - Venezuela 21
GT - Guatemala 20
TT - Trinidad e Tobago 20
EU - Europa 19
NI - Nicaragua 19
SA - Arabia Saudita 19
EC - Ecuador 18
GR - Grecia 18
JM - Giamaica 18
NL - Olanda 18
CO - Colombia 16
HN - Honduras 16
PH - Filippine 16
MA - Marocco 15
SV - El Salvador 15
UZ - Uzbekistan 14
ID - Indonesia 12
KE - Kenya 12
CL - Cile 11
CW - ???statistics.table.value.countryCode.CW??? 11
AU - Australia 10
IR - Iran 10
JO - Giordania 10
AZ - Azerbaigian 9
EE - Estonia 9
LT - Lituania 9
MY - Malesia 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 7
EG - Egitto 7
PR - Porto Rico 7
GP - Guadalupe 6
AT - Austria 5
DZ - Algeria 5
ET - Etiopia 5
NP - Nepal 5
OM - Oman 5
PE - Perù 5
TN - Tunisia 5
UY - Uruguay 5
NZ - Nuova Zelanda 4
RO - Romania 4
RS - Serbia 4
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
KZ - Kazakistan 3
PA - Panama 3
PT - Portogallo 3
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GD - Grenada 2
HU - Ungheria 2
LB - Libano 2
NG - Nigeria 2
SY - Repubblica araba siriana 2
BM - Bermuda 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HT - Haiti 1
Totale 28.774
Città #
Singapore 1.683
Jacksonville 1.440
San Jose 1.360
Chandler 1.242
Dublin 1.023
Southend 812
Dallas 729
Ashburn 599
Izmir 523
Council Bluffs 509
Princeton 489
Beijing 430
Nanjing 419
Dearborn 418
Wilmington 346
Cambridge 259
Los Angeles 232
Tongling 213
New York 210
Buffalo 199
Santa Clara 190
Ann Arbor 180
Ho Chi Minh City 146
Nanchang 141
Boardman 140
Woodbridge 130
Grevenbroich 99
Hanoi 98
Moscow 97
The Dalles 95
Altamura 94
Columbus 79
São Paulo 75
Houston 74
Hefei 71
Shenyang 69
Hebei 67
Tianjin 64
Chieti 58
Jiaxing 56
Kunming 51
Phoenix 51
Redondo Beach 51
Chicago 47
Milan 47
Hong Kong 44
Toronto 44
Silver Spring 43
Jinan 42
Hangzhou 41
Norwalk 41
Orange 40
Rome 40
Changsha 39
Orem 39
Augusta 36
Warsaw 36
North Bergen 35
Montreal 34
San Mateo 34
Helsinki 33
London 32
Atlanta 31
Brussels 31
Chennai 31
Brooklyn 30
Denver 30
Brno 29
Munich 29
Seoul 29
Tokyo 29
Boston 27
Dong Ket 26
Kimball 26
Grafing 24
Guangzhou 24
Washington 24
Manchester 23
Rio de Janeiro 23
San Francisco 23
Da Nang 22
Johannesburg 21
Mexico City 21
Mumbai 20
Ottawa 20
Queens 20
Frankfurt am Main 19
Philadelphia 19
Romola 19
San José 19
Andover 18
Ningbo 18
Auburn Hills 17
Leawood 17
Managua 17
Seattle 17
Guatemala City 16
Haiphong 15
Naples 14
San Salvador 14
Totale 16.910
Nome #
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. 1.271
Tamoxifene e quercetina inibiscono la proliferazione di cellule neoplastiche polmonari "non small cell" in coltura e nei tumori primitivi. 263
Ruolo della IL-1 nella regolazione della produzione del TGFbeta1 e della IL-8 nei tumori del polmone "non-small cell". 199
Role of GM-CSF in cryptogenic organizing pneumonia 199
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 188
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 184
Apoptosi spontanea ed indotta da glicocorticoidi nei linfociti T periferici umani 183
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 180
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 175
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. 171
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 169
Transforming growth factor beta1, interleukin-8 and interleukin-1 in human non-small cell lung tumor cell lines and primary tumors. 168
TGF-beta-1 and IL-8 in human long cancer cell lines and primary tumors: constitutive production and modulation by IL-1 166
A solid phase radioimmunoassay for the diagnosis of human hydatidosis. 165
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 164
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 164
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 163
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 163
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 161
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 160
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung. 158
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. 158
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 156
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 155
5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory 154
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 153
Growth inhibitory mechanism of quercetin and tamoxifen in human lung cancer cell lines 153
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 152
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 152
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 151
Carcinomi polmonari umani: produzione di TGFbeta1 149
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 149
Analysis of IL-2-receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer. 146
INTERACTION WITH TYPE II ESTROGEN BINDING SITES AND ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN AND QUERCETIN IN HUMAN NON SMALL CELL LUNG CANCER. 146
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 146
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 146
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 145
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 145
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome. 144
Cellule immunocompetenti associate alla mucosa nella patologia della cervice uterina dei soggetti HIV-infetti 143
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 143
T3 expression by human thymocytes in culture. 143
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 143
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 143
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). 141
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. 140
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 139
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 139
Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipients. 139
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids. 139
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. 138
Growth inhibitory effect of quercetin and tamoxifen and presence of type II estrogen-binding sites in human lung cancer cell lines and primary tumors 136
Alloantisera defining surface antigens on human thymocytes. 136
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 135
Neutrophils in anti-cancer immunological strategies: old players in new games 133
Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. 133
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 132
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 132
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 132
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 131
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients. 131
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 131
Polymorphonuclear Leukocyte Apoptosis is Inhibited by Platelet-released mediators, Role of TGFbeta-1 130
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 130
Alpha-l-antitrypsin deficiency and human pathology. 130
IL-10 potentiates the effect of dexamethasone in inhibiting the proliferation of resting, activated and "corticoresistant" human T cells 130
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 129
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. 129
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 128
Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis. 128
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 127
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 127
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 127
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 127
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 127
Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. 126
Inactivation of the IL-6 gene prevents development of multricentric Castleman's disease in C/EBP beta-deficient mice 126
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. 126
Glucocorticoid inhibitory action on OKT3 stimulated peripheral blood lymphocytes from renal transplant patients. 126
The Mutyh base excision repair gene influences the inflammatory response in a mouse model of ulcerative colitis. 126
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 126
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 125
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 125
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 125
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 125
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 125
Antimetastatic activity of a preventive cancer vaccine. 125
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. 123
Proliferative capabilities of T3-positive thymocytes. 123
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 123
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 122
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 122
A human thymoma with prothymocyte-like infiltration. 122
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth. 121
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 121
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 121
Alpha-1-antitrypsin in umbilical cord serum: pi phenotypes and relationships with idiopathic respiratory distress syndrome. 121
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 121
Immune cell characterization and cytokine detection in inflammatory bowel disease. 120
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors. 120
Totale 15.421
Categoria #
all - tutte 109.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022764 0 0 0 0 142 32 33 82 65 30 120 260
2022/20233.405 293 295 163 444 375 769 203 258 443 38 71 53
2023/20241.378 136 49 65 35 101 425 363 40 11 20 14 119
2024/20253.307 224 488 399 75 61 49 36 238 389 150 366 832
2025/20267.882 631 442 981 699 461 513 1.134 571 1.323 549 442 136
2026/20272.546 130 431 303 1.233 449 0 0 0 0 0 0 0
Totale 29.092